Skip to content

Electrolyte Balance Effects of Sterofundin Versus Normal Saline in Diabetic Ketoacidosis

Electrolyte Balance Effects of Sterofundin Versus Normal Saline in Diabetic Ketoacidosis

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06399510
Enrollment
58
Registered
2024-05-03
Start date
2024-03-01
Completion date
2025-04-30
Last updated
2024-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Treatment Diabetic Ketoacidosis, Electrolyte Balance Effects

Brief summary

The goal of this prospective single centered randomized control trial is to compare the electrolyte balance effects between Sterofundin and Normal Saline in Diabetic Ketoacidosis patients. The main questions it aims to answer are: i. Is there any difference in duration of bicarbonate (HCO3-) to reach equal or more than 15mmol/L from the initial blood taking in between Sterofundin and NS fluid use in DKA patients? ii. Is there any difference in the level of post-infusion serum sodium (Na+) between Sterofundin and NS fluid use in DKA patients? iii. Is there any difference in the level of post-infusion serum potassium (K+) between Sterofundin and NS fluid use in DKA patients? Patients will be randomized in a 1:1 ratio to receive IV Sterofundin (intervention) or IV Normal Saline (standard care). The patient will have the respective fluid regime as the main fluid therapy during the first 24 hours of ICU stay. If patients were randomized to the control arm, the fluid regime for the first 24 hours in ICU will be normal saline. If patients were randomized to the interventional arm, the main fluid therapy during the first 24 hours of ICU stay will be Sterofundin.

Interventions

OTHERSterofundin fluid therapy

Sterofundin is known as balanced solution which has similar electrolytes content as per human plasma.

Sponsors

Universiti Sains Malaysia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* DKA. * Aged ≥ 18 years old. * Patients admitted to ICU \< 12 hours after initial fluid resuscitation from emergency department/ ward.

Exclusion criteria

* End stage renal failure * Heart failure * Started treatment of sodium bicarbonate infusion prior to ICU admission * Known allergy to Sterofundin

Design outcomes

Primary

MeasureTime frame
The duration taken for serum HCO3 ≥ 15 within 24 hours ICU admission.24 Hours
Mean difference of serum sodium level between Sterofundin and normal saline fluid use in diabetic ketoacidosis patients24 Hours
Mean difference of serum potassium level between Sterofundin and normal saline fluid use in diabetic ketoacidosis patients.24 Hours

Secondary

MeasureTime frame
The Need of Renal Replacement Therapy30 days
Mechanical ventilation day30 days

Countries

Malaysia

Contacts

Primary ContactShi Jie How
shijie.how@gmail.com+601151362495

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026